Alder BioPharmaceuticals to Present at the 35th Annual J.P. Morgan Healthcare Conference Jan 2, 2017 08:00AM
Alder BioPharma (ALDR) Commences Second Pivotal Eptinezumab Phase 3 in Migraines Nov 28, 2016 08:01AM
Alder BioPharmaceuticals Initiates PROMISE 2 Pivotal Trial of Eptinezumab for the Prevention of Migraine Nov 28, 2016 08:00AM
Alder BioPharmaceuticals to Present at Two Upcoming November Conferences Nov 1, 2016 08:00AM
Alder BioPharmaceuticals Announces Third Quarter 2016 Financial and Operating Results Oct 27, 2016 04:02PM


Oct 20, 2016 08:00AM Alder BioPharmaceuticals to Host Conference Call to Discuss Third Quarter 2016 Financial and Operating Results
Oct 11, 2016 08:06AM Alder BioPharma (ALDR) Appoints New CFO, PAO
Oct 11, 2016 08:00AM Alder BioPharmaceuticals Promotes Larry Benedict to Executive Vice President of Finance and Principal Accounting Officer
Sep 21, 2016 08:00AM Alder BioPharmaceuticals Appoints Nancy L. Boman, M.D., Ph.D., Senior Vice President of Regulatory Affairs and Pharmacovigilance
Sep 15, 2016 08:01AM Alder BioPharma (ALDR) Announces Presentation of Positive ALD403 Phase 2b Data in Migraine Prevention
Sep 15, 2016 08:00AM Alder Presents Positive ALD403 Clinical Data at European Headache and Migraine Trust International Congress
Sep 8, 2016 08:00AM Alder Announces Presentations at the European Headache and Migraine Trust International Congress Supporting Development of ALD403 for Migraine Prevention
Sep 6, 2016 08:00AM Alder BioPharmaceuticals Appoints Elisabeth A. Sandoval as Chief Commercial Officer
Aug 31, 2016 08:00AM Alder BioPharmaceuticals to Present at Two Upcoming September Healthcare Conferences
Jul 26, 2016 04:05PM Alder BioPharmaceuticals Reports Second Quarter 2016 Financial and Operating Results
Jul 25, 2016 08:04AM Alder BioPharma (ALDR) Announces Positive Top-Line Data from ALD403 Phase 2b
Jul 25, 2016 08:00AM Alder Reports Positive Top-Line 24-Week Data Demonstrating Persistent Migraine Prevention in Phase 2b Study of ALD403 in Patients with Chronic Migraine
Jul 19, 2016 08:00AM Alder BioPharmaceuticals to Host Conference Call to Discuss Second Quarter 2016 Financial and Operating Results
Jun 29, 2016 08:00AM Alder BioPharmaceuticals Appoints Timothy M. Whitaker, M.D., Chief Medical Officer